India's new drug approval process waiver raises concerns about patient safety, research, and healthcare implications, experts ...

In a significant breakthrough for those suffering from chronic hand eczema, a widespread skin condition resistant to existing ...

Clinical trials in 2025 will be beset by rising costs and uncertain regulations while also benefiting from new technologies ...

Some 90% of investigational drugs fail—and success rates are even more dire in the neuro space. Here, BioSpace looks at five ...

A patient advocate discusses the difficulties of finding and participating in clinical trials for MPNs, and the impact on ...

China: A new randomized clinical trial has demonstrated that QX004N, a humanized anti-IL-23 monoclonal antibody, offers ...

Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug discovery ...

Viracta Therapeutics shares were trading lower after it said it will end an ongoing trial of Nana-val and its board has initiated a process to explore strategic options. The strategic options being ...

The clinical trial will assess CMND-100’s ability to reduce alcohol cravings and consumption among individuals with moderate to severe AUD. The study is designed to gather critical data supporting the ...

About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.

The Eclipse Trial is researching an investigational vaccine to protect against Epstein-Barr virus (EBV) and infectious ...

PainReform previously disclosed initial topline data from its Phase 3 clinical trial in which it reported that it demonstrated statistically significant superiority over placebo in reducing pain ...